A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)
This study has been completed.
Study NCT00258063
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received on November 22, 2005.
Last Updated on June 6, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
